Educational inequality in multimorbidity: causality and causal pathways. A mendelian randomisation study in UK Biobank.


Journal

BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562

Informations de publication

Date de publication:
28 08 2023
Historique:
received: 24 02 2023
accepted: 24 07 2023
medline: 31 8 2023
pubmed: 29 8 2023
entrez: 28 8 2023
Statut: epublish

Résumé

Multimorbidity, typically defined as having two or more long-term health conditions, is associated with reduced wellbeing and life expectancy. Understanding the determinants of multimorbidity, including whether they are causal, may help with the design and prioritisation of prevention interventions. This study seeks to assess the causality of education, BMI, smoking and alcohol as determinants of multimorbidity, and the degree to which BMI, smoking and alcohol mediate differences in multimorbidity by level of education. Participants were 181,214 females and 155,677 males, mean ages 56.7 and 57.1 years respectively, from UK Biobank. We used a Mendelian randomization design; an approach that uses genetic variants as instrumental variables to interrogate causality. The prevalence of multimorbidity was 55.1%. Mendelian randomization suggests that lower education, higher BMI and higher levels of smoking causally increase the risk of multimorbidity. For example, one standard deviation (equivalent to 5.1 years) increase in genetically-predicted years of education decreases the risk of multimorbidity by 9.0% (95% CI: 6.5 to 11.4%). A 5 kg/m Education, BMI, smoking and alcohol consumption are intervenable causal risk factors for multimorbidity. Furthermore, BMI and lifetime smoking make a considerable contribution to the generation of educational inequalities in multimorbidity. Public health interventions that improve population-wide levels of these risk factors are likely to reduce multimorbidity and inequalities in its occurrence.

Sections du résumé

BACKGROUND
Multimorbidity, typically defined as having two or more long-term health conditions, is associated with reduced wellbeing and life expectancy. Understanding the determinants of multimorbidity, including whether they are causal, may help with the design and prioritisation of prevention interventions. This study seeks to assess the causality of education, BMI, smoking and alcohol as determinants of multimorbidity, and the degree to which BMI, smoking and alcohol mediate differences in multimorbidity by level of education.
METHODS
Participants were 181,214 females and 155,677 males, mean ages 56.7 and 57.1 years respectively, from UK Biobank. We used a Mendelian randomization design; an approach that uses genetic variants as instrumental variables to interrogate causality.
RESULTS
The prevalence of multimorbidity was 55.1%. Mendelian randomization suggests that lower education, higher BMI and higher levels of smoking causally increase the risk of multimorbidity. For example, one standard deviation (equivalent to 5.1 years) increase in genetically-predicted years of education decreases the risk of multimorbidity by 9.0% (95% CI: 6.5 to 11.4%). A 5 kg/m
CONCLUSIONS
Education, BMI, smoking and alcohol consumption are intervenable causal risk factors for multimorbidity. Furthermore, BMI and lifetime smoking make a considerable contribution to the generation of educational inequalities in multimorbidity. Public health interventions that improve population-wide levels of these risk factors are likely to reduce multimorbidity and inequalities in its occurrence.

Identifiants

pubmed: 37641019
doi: 10.1186/s12889-023-16369-1
pii: 10.1186/s12889-023-16369-1
pmc: PMC10463319
doi:

Substances chimiques

Ethanol 3K9958V90M

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1644

Subventions

Organisme : Medical Research Council
ID : MC_UU_00011/6
Pays : United Kingdom
Organisme : British Heart Foundation
ID : AA/18/7/34219
Pays : United Kingdom
Organisme : Department of Health
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/M020894/1
Pays : United Kingdom

Informations de copyright

© 2023. BioMed Central Ltd., part of Springer Nature.

Références

National Guideline Centre. Multimorbidity: clinical assessment and management. London: National Institute for Health and Care Excellence; 2016.
Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. The Lancet. 2012;380(9836):37–43.
doi: 10.1016/S0140-6736(12)60240-2
US Department of Health and Human Services. Multiple chronic conditions - a strategic framework: optimum health and quality of life for individuals with multiple chronic conditions. Washington, DC; 2010.
Katikireddi SV, Skivington K, Leyland AH, Hunt K, Mercer SW. The contribution of risk factors to socioeconomic inequalities in multimorbidity across the lifecourse: a longitudinal analysis of the Twenty-07 cohort. BMC Med. 2017;15(1):152.
doi: 10.1186/s12916-017-0913-6 pubmed: 28835246 pmcid: 5569487
Mutz J, Roscoe CJ, Lewis CM. Exploring health in the UK Biobank: associations with sociodemographic characteristics, psychosocial factors, lifestyle and environmental exposures. BMC Med. 2021;19(1):240.
doi: 10.1186/s12916-021-02097-z pubmed: 34629060 pmcid: 8504077
Lawlor DA, Harbord RM, Sterne JAC, Timpson N, Davey Smith G. Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med. 2008;27(8):1133–63.
doi: 10.1002/sim.3034 pubmed: 17886233
Davies NM, Holmes MV, Davey Smith G. Reading mendelian randomisation studies: a guide, glossary, and checklist for clinicians. BMJ. 2018;362:k601.
doi: 10.1136/bmj.k601 pubmed: 30002074 pmcid: 6041728
Zheng J, Baird D, Borges M-C, Bowden J, Hemani G, Haycock P, et al. Recent developments in mendelian randomization studies. Curr Epidemiol Rep. 2017;4(4):330–45.
doi: 10.1007/s40471-017-0128-6 pubmed: 29226067 pmcid: 5711966
Burgess S, Thompson SG. Multivariable mendelian randomization: the Use of Pleiotropic Genetic Variants to Estimate Causal Effects. Am J Epidemiol. 2015;181(4):251–60.
doi: 10.1093/aje/kwu283 pubmed: 25632051 pmcid: 4325677
North T-L, Davies NM, Harrison S, Carter AR, Hemani G, Sanderson E, et al. Using Genetic Instruments to Estimate interactions in mendelian randomization studies. Epidemiology. 2019;30(6):e33–e5.
doi: 10.1097/EDE.0000000000001096 pubmed: 31469698
Allen NE, Sudlow C, Peakman T, Collins R. UK Biobank Data: come and get it. Sci Transl Med. 2014;6(224):224ed4.
doi: 10.1126/scitranslmed.3008601 pubmed: 24553384
Collins R. What makes UK Biobank special? The Lancet. 2012;379(9822):1173–4.
doi: 10.1016/S0140-6736(12)60404-8
Okbay A, Beauchamp JP, Fontana MA, Lee JJ, Pers TH, Rietveld CA, et al. Genome-wide association study identifies 74 loci associated with educational attainment. Nature. 2016;533:539.
doi: 10.1038/nature17671 pubmed: 27225129 pmcid: 4883595
Leffondré K, Abrahamowicz M, Xiao Y, Siemiatycki J. Modelling smoking history using a comprehensive smoking index: application to lung cancer. Stat Med. 2006;25(24):4132–46.
doi: 10.1002/sim.2680 pubmed: 16998807
Wootton RE, Richmond RC, Stuijfzand BG, Lawn RB, Sallis HM, Taylor GMJ, et al. Evidence for causal effects of lifetime smoking on risk for depression and schizophrenia: a mendelian randomisation study. Psychol Med. 2020;50(14):2435–43.
doi: 10.1017/S0033291719002678 pubmed: 31689377
Clarke TK, Adams MJ, Davies G, Howard DM, Hall LS, Padmanabhan S, et al. Genome-wide association study of alcohol consumption and genetic overlap with other health-related traits in UK Biobank (N = 112 117). Mol Psychiatry. 2017;22(10):1376–84.
doi: 10.1038/mp.2017.153 pubmed: 28937693 pmcid: 5622124
Payne RA, Mendonca SC, Elliott MN, Saunders CL, Edwards DA, Marshall M, et al. Development and validation of the Cambridge Multimorbidity score. Can Med Assoc J. 2020;192(5):E107.
doi: 10.1503/cmaj.190757
Mitchell R, Hemani G, Dudding T, Corbin L, Harrison S, Paternoster L. UK Biobank Genetic Data: MRC-IEU Quality Control, version 2 2019
Baum CF, Schaffer ME, Stillman S. ivreg2: Stata module for extended instrumental variables/2SLS, GMM and AC/HAC, LIML and k-class regression 2010. http://ideas.repec.org/c/boc/bocode/s425401.html .
StataCorp. Stata Statistical Software: release 16. College Station. TX: StataCorp LLC; 2019.
Hartwig FP, Davies NM, Hemani G, Davey Smith G. Two-sample mendelian randomization: avoiding the downsides of a powerful, widely applicable but potentially fallible technique. Int J Epidemiol. 2017;45(6):1717–26.
doi: 10.1093/ije/dyx028 pmcid: 5722032
Loh P-R, Tucker G, Bulik-Sullivan BK, Vilhjálmsson BJ, Finucane HK, Salem RM, et al. Efficient bayesian mixed-model analysis increases association power in large cohorts. Nat Genet. 2015;47(3):284–90.
doi: 10.1038/ng.3190 pubmed: 25642633 pmcid: 4342297
McVean GA, Altshuler DM, Durbin RM, Abecasis GR, Bentley DR, Chakravarti A, et al. An integrated map of genetic variation from 1,092 human genomes. Nature. 2012;491(7422):56–65.
doi: 10.1038/nature11632 pubmed: 23128226
Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–60.
doi: 10.1136/bmj.327.7414.557 pubmed: 12958120 pmcid: 192859
Higgins JP, Thompson SG. Controlling the risk of spurious findings from meta-regression. Stat Med. 2004;23(11):1663–82.
doi: 10.1002/sim.1752 pubmed: 15160401
Harris RJ, Bradburn MJ, Deeks JJ, Harbord RM, Altman DG, Sterne JAC. Metan: fixed- and random-effects meta-analysis. Stata J. 2008;8(1):3–28.
doi: 10.1177/1536867X0800800102
Spiller W, Davies NM, Palmer TM. Software application profile: mrrobust—a tool for performing two-sample summary mendelian randomization analyses. Int J Epidemiol. 2019;48(3):684–90.
doi: 10.1093/ije/dyy195
Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol. 2015;44(2):512–25.
doi: 10.1093/ije/dyv080 pubmed: 26050253 pmcid: 4469799
Burgess S, Butterworth A, Thompson SG. Mendelian randomization analysis with multiple genetic variants using Summarized Data. Genet Epidemiol. 2013;37(7):658–65.
doi: 10.1002/gepi.21758 pubmed: 24114802 pmcid: 4377079
Hartwig FP, Davey Smith G, Bowden J. Robust inference in summary data mendelian randomization via the zero modal pleiotropy assumption. Int J Epidemiol. 2017;46(6):1985–98.
doi: 10.1093/ije/dyx102 pubmed: 29040600 pmcid: 5837715
Bowden J, Davey Smith G, Haycock PC, Burgess S. Consistent estimation in mendelian randomization with some Invalid Instruments using a weighted median estimator. Genet Epidemiol. 2016;40.
Sanderson E, Davey Smith G, Windmeijer F, Bowden J. An examination of multivariable mendelian randomization in the single sample and two-sample summary data settings. bioRxiv. 2018.
Carter AR, Sanderson E, Hammerton G, Richmond RC, Davey Smith G, Heron J, et al. Mendelian randomisation for mediation analysis: current methods and challenges for implementation. Eur J Epidemiol. 2021;36(5):465–78.
doi: 10.1007/s10654-021-00757-1 pubmed: 33961203 pmcid: 8159796
Daniel R. GFORMULA. Stata module to implement the g-computation formula for estimating causal effects in the presence of time-varying confounding or mediation. Statistical Software Components S457204. Revised 29 September 2021 ed. Boston College Department of Economics; 2010.
R Core Team. R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2019.
Newson R. RSOURCE. Stata Module to run R from inside Stata using an R source file. revised 09 May 2016 ed. Boston College Department of Economics Statistical Software Components S456847; 2007.
Wickham H. Reshaping data with the reshape package. J Stat Softw. 2007;21(12).
Dowle M, Srinivasan A. data.table: Extension of data.frame. 2021.
Wickham H. The Split-Apply-combine strategy for Data Analysis. J Stat Softw. 2011;40(1):1–29.
doi: 10.18637/jss.v040.i01
Wickham H, Francois R, Henry L, Muller K. dplyr: A Grammar of Data Manipulation R Package Version 1.0.4. 2021.
Bengtsson H. Rutils. Various Programming Utilities R Package Version 2.10.1. 2020.
Wickham H, Hester J, Chang W. devtools: Tools to Make Developing R Packages Easier R Package Version 2.2.0. 2019.
Howe LD, Kanayalal R, Harrison S, Beaumont RN, Davies AR, Frayling TM, et al. Effects of body mass index on relationship status, social contact and socio-economic position: mendelian randomization and within-sibling study in UK Biobank. Int J Epidemiol. 2020;49(4):1173–84.
doi: 10.1093/ije/dyz240 pubmed: 31800047
Harrison S, Davies AR, Dickson M, Tyrrell J, Green MJ, Katikireddi SV, et al. The causal effects of health conditions and risk factors on social and socioeconomic outcomes: mendelian randomization in UK Biobank. Int J Epidemiol. 2020;49(5):1661–81.
doi: 10.1093/ije/dyaa114 pubmed: 32808034 pmcid: 7746412
Cassell A, Edwards D, Harshfield A, Rhodes K, Brimicombe J, Payne R, et al. The epidemiology of multimorbidity in primary care: a retrospective cohort study. Br J Gen Pract. 2018;68(669):e245–e51.
doi: 10.3399/bjgp18X695465 pubmed: 29530918 pmcid: 5863678
Blakely T, McKenzie S, Carter K. Misclassification of the mediator matters when estimating indirect effects. J Epidemiol Commun Health. 2013;67(5):458.
doi: 10.1136/jech-2012-201813
Tyrrell J, Mulugeta A, Wood AR, Zhou A, Beaumont RN, Tuke MA, et al. Using genetics to understand the causal influence of higher BMI on depression. Int J Epidemiol. 2018;48(3):834–48.
doi: 10.1093/ije/dyy223 pmcid: 6659462
Li W, Peng Y, Chen D, Lu Z, Tao Y. Association of weight change across adulthood with hearing loss: a retrospective cohort study. Int J Obes. 2022;46(10):1825–32.
doi: 10.1038/s41366-022-01197-x
Garcia Morales EE, Ting J, Gross AL, Betz JF, Jiang K, Du S, et al. Association of cigarette smoking patterns over 30 years with audiometric hearing impairment and Speech-in-noise perception: the atherosclerosis risk in Communities Study. JAMA Otolaryngology–Head & Neck Surgery. 2022;148(3):243–51.
doi: 10.1001/jamaoto.2021.3982
Fry A, Littlejohns TJ, Sudlow C, Doherty N, Adamska L, Sprosen T, et al. Comparison of Sociodemographic and Health-Related characteristics of UK Biobank participants with those of the General Population. Am J Epidemiol. 2017;186(9):1026–34.
doi: 10.1093/aje/kwx246 pubmed: 28641372 pmcid: 5860371
Beard E, Brown J, West R, Kaner E, Meier P, Michie S. Associations between socio-economic factors and alcohol consumption: a population survey of adults in England. PLoS ONE. 2019;14(2):e0209442.
doi: 10.1371/journal.pone.0209442 pubmed: 30716098 pmcid: 6361426
Sun Y-Q, Burgess S, Staley JR, Wood AM, Bell S, Kaptoge SK, et al. Body mass index and all cause mortality in HUNT and UK Biobank studies: linear and non-linear mendelian randomisation analyses. BMJ. 2019;364:l1042.
doi: 10.1136/bmj.l1042 pubmed: 30957776 pmcid: 6434515

Auteurs

Teri-Louise North (TL)

MRC Integrative Epidemiology Unit, Population Health Sciences, University of Bristol, Bristol, UK. teri.north@bristol.ac.uk.

Sean Harrison (S)

MRC Integrative Epidemiology Unit, Population Health Sciences, University of Bristol, Bristol, UK.

Deborah C Bishop (DC)

MRC Integrative Epidemiology Unit, Population Health Sciences, University of Bristol, Bristol, UK.

Robyn E Wootton (RE)

MRC Integrative Epidemiology Unit, Population Health Sciences, University of Bristol, Bristol, UK.
Nic Waals Institute, Lovisenberg Diaconal Hospital, Oslo, Norway.
School of Psychological Science, University of Bristol, Bristol, UK.

Alice R Carter (AR)

MRC Integrative Epidemiology Unit, Population Health Sciences, University of Bristol, Bristol, UK.

Tom G Richardson (TG)

MRC Integrative Epidemiology Unit, Population Health Sciences, University of Bristol, Bristol, UK.

Rupert A Payne (RA)

Centre for Academic Primary Care, Population Health Sciences, University of Bristol, Bristol, UK.
Exeter Collaboration for Academic Primary Care, Department of Health and Community Sciences, University of Exeter, Exeter, UK.

Chris Salisbury (C)

Centre for Academic Primary Care, Population Health Sciences, University of Bristol, Bristol, UK.

Laura D Howe (LD)

MRC Integrative Epidemiology Unit, Population Health Sciences, University of Bristol, Bristol, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH